Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
From 2019 to 2023, a total of 30.8602 million doses of non-National Immunization Program (non-NIP) vaccines were administered in Shaanxi Province, averaging 1 561 doses per 10 000 population. The annual administration of non-NIP vaccines increased from 4.359 1 million doses in 2019 to 7.858 2 million doses in 2023, with their proportional representation among all vaccines rising from 30.82% to 55.15%(=2 440 581.54, <0.001). The administration rate per 10 000 population increased from 1 105 doses to 1 986 doses during this period(=373.10, <0.001). Concurrently, the substitution rate of non-NIP vaccines for National Immunization Program vaccines rose from 4.94% in 2019 to 16.11% in 2023.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3760/cma.j.cn112150-20240604-00447 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epidemiology of hand, foot, and mouth disease outbreaks before and during availability of EV-A71 vaccine in China's mainland: analysis of outbreak surveillance data from 2011 to 2023.
Lancet Reg Health West Pac
June 2025
Department of Health Policy and Management, School of Public Health, Peking University, No. 38, Xueyuan Road, Haidian District, Beijing, 100191, PR China.
Background: Hand, foot, and mouth disease is a common contagious illness of childhood that causes a heavy disease burden in China's mainland. There are three enterovirus A71 (EV-A71) vaccines licensed and used in China since 2016. Our study describes changes in epidemiological characteristics of HFMD outbreaks following EV-A71 vaccine introduction.
View Article and Find Full Text PDF[Analysis of non-national immunization program vaccines inoculated in Shaanxi Province from 2019 to 2023].
Zhonghua Yu Fang Yi Xue Za Zhi
May 2025
Department of Immunization Program, Shaanxi Provincial Center for Disease Control and Prevention, Xi'an 710054, China.
From 2019 to 2023, a total of 30.8602 million doses of non-National Immunization Program (non-NIP) vaccines were administered in Shaanxi Province, averaging 1 561 doses per 10 000 population. The annual administration of non-NIP vaccines increased from 4.
View Article and Find Full Text PDFIndependent and joint associations of sex and birth order with non‑national immunization program vaccine coverage among Chinese children: a cross-sectional analysis.
Int J Equity Health
May 2025
School of Public Health, The Second Affiliated Hospital, Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou, 310058, Zhejiang, China.
Background: In response to declining fertility rates, China implemented universal two- and three-child policies, leading to an increase of multi-child families. However, little is known whether and how these policy changes influenced the uptake of non-National Immunization Program (non-NIP) vaccines. We evaluated associations of sex and birth order with non-NIP vaccine coverage in 1-6-year-old children in China.
View Article and Find Full Text PDFSentinel Safety Monitoring System for Adverse Events of Special Interest Associated With Non-NIP Vaccines in Korea.
J Korean Med Sci
April 2025
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
South Korea's current vaccination policies leave a surveillance gap for non-National Immunization Program (NIP) vaccines. In this study, we proposed a sentinel surveillance approach for monitoring the safety of non-NIP vaccines. Vaccination data were collected retrospectively among patients hospitalized with pre-defined adverse events of special interest (AESI) by reviewing electronic medical records in five university hospitals.
View Article and Find Full Text PDF'Immune from the germ-laden things': Immunity and Irish Newspaper Advertising, 1890-1940.
Soc Hist Med
November 2024
English Programme, University of Waikato, Hamilton, New Zealand.
From 1890, as advertising in Irish newspapers grew in quantity and sophistication, a discourse of immunity began to circulate. Advertisers drew on advancements in bacteriology and immunology to present their goods as defensive strategies against a range of threats, from major infectious diseases to everyday coughs and colds. Consumers were urged to supplement their bodies' vulnerabilities by purchasing pills and tonics, with medical products joined by immunity-assuring underwear, coats, cosmetics and cars.
View Article and Find Full Text PDF